Quarterly and annual results disclosed under 8-K Item 2.02.
KINGSTONE COMPANIES, INC. reported financial results for the fourth quarter and year ended December 31, 2023.
“On March 27, 2024, Kingstone Companies, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2023 (the “Press Release”).”
Forza X1, Inc. reported financial results for the year ended December 31, 2023.
“On March 26, 2024, Forza X1, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year ended December 31, 2023.”
Drilling Tools International Corp reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $152 million, net income $14.7 million.
“and offshore horizontal and directional drilling operations, today reported its 2023 full year results and provided its 2024 full year outlook. 2023 Full Year Highlights Revenue $152 million Net Income $14.7 million Adjusted EBITDA (1) $51 million Adjusted EBITDA Margin (1) 33.6% Adjusted Free Cash Flow (1)(2) $7.3 million Wayne Prejean, CEO of DTI, stated, “We are”
Sidus Space Inc. reported the full year ended December 31, 2023 results: revenue approximately $6.0 million, net income $14.3 million.
“Financial Highlights for the Full Year Ending December 31, 2023: Total revenue for the twelve months ended December 31, 2023 totaled approximately $6.0 million, a decrease of $1.3 million compared to total revenue for the twelve months ended December 31, 2022. This decrease was primarily driven by the timing of fixed price milestone contracts offset by satellite payload revenue. Cost of revenue decreased 26% for the twelve months ended December 31, 2023 to approximately $4.3 million as compared to approximately $5.9 million for the twelve months ended December 31, 2022. The decrease was primarily driven by a mix of contracts and an increase in our higher margin satellite related business, which helped offset continued increased supply chain related costs in the manufacturing side of our business. Gross profit increased 14% for the twelve months ended December 31, 2023 to approximately $1.6 million as compared to approximately $1.4 million for the twelve months ended December 31, 202”
Twin Vee PowerCats, Co. reported the fiscal year ended December 31, 2023 results: revenue $33,426,000, net income net loss of $2,348,000.
“highlights and financial results for fiscal year ended December 31, 2023. Highlights for fiscal year 2023 : · Revenue for the year ended December 31, 2023 increased 4% to $33,426,000 as compared to $31,988,000 in 2022. · Twin Vee had a net loss of $2,348,000 for the year ended December 31, 2023, as compared to a net loss of $2,144,000 in 2022. · Aquasport had”
Local Bounti Corporation/DE reported the three and twelve months ended December 31, 2023 results: revenue $27.6 million, net income $124.0 million.
“scale from our capacity expansions in 2024 has us on track to drive positive adjusted EBITDA 1 in early 2025." Full Year 2023 Financial Summary • Sales increased 42% to $27.6 million in 2023, as compared to $19.5 million in the prior year period. The increase was primarily due to inclusion of the April 2022 Pete's acquisition in our results for the full”
Rumble Inc. reported financial results for the quarter and fiscal year ended December 31, 2023.
“On March 27, 2024, Rumble Inc. (the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2023.”
Sky Harbour Group Corp reported financial results for the year ended December 31, 2023.
“On March 27, 2024, the Company issued a press release (the “Press Release”) which announced its financial results for the year ended December 31, 2023.”
Playboy, Inc. reported financial results for fourth quarter and full year ended December 31, 2023.
“On March 27, 2024, PLBY Group, Inc. (the “Company”) issued a press release announcing its financial results for the Company’s fourth fiscal quarter and fiscal year ended December 31, 2023.”
Oncology Institute, Inc. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $86 million, net income $18.8 million, EPS $(0.21).
“Officer. • Hired 7 new providers in the quarter and ended the year with 69 clinics and 119 employed providers. Fourth Quarter 2023 Financial Highlights • Consolidated revenue of $86 million, an increase of 20.1% compared to the prior year quarter • Gross profit of $14 million, a decrease of 8.0% compared to the prior year quarter • Net loss of $18.8 million compared”
Metagenomi Therapeutics, Inc. reported financial results for the full year ended December 31, 2023.
“On March 27, 2024, Metagenomi, Inc. announced its financial results for the year ended December 31, 2023 and additional business updates.”
Erasca, Inc. reported financial results for the fiscal quarter and full year ended December 31, 2023.
“On March 27, 2024, Erasca, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2023.”
Mereo BioPharma Group plc reported financial results for the year ended December 31, 2023.
“On March 27, 2024, Mereo BioPharma Group plc announced its financial results for the year ended December 31, 2023.”
Allied Gaming & Entertainment Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $7.7 million, net income Net loss (including the amount attributable to non-controlling interests) was $3.6 million in 2023.
“of the GAAP-basis net loss to adjusted EBITDA is provided in the table at the end of this press release. Fourth Quarter 2023 Financial Results Revenues: Total revenues of $2.1 million increased 70% for the fourth quarter of 2023 compared to the fourth quarter of 2022. The increase from the fourth quarter of 2022 was driven by an increase in HyperX sponsorship”
urban-gro, Inc. reported First Quarter 2024 results: revenue at or better than $15.0 million. Guidance initiated.
“First Quarter 2024 Preliminary Guidance vs Prior Year Period: • Revenue at or better than $15.0 million, as compared to $16.8 million • Adjusted EBITDA 1 at or better than ($0.5) million, as compared to $(3.4) million”
urban-gro, Inc. reported Full Year 2024 results: revenue more than $84.0 million. Guidance initiated.
“Full Year 2024 Guidance • Revenue of more than $84.0 million , representing growth of at least 17.4% • Positive Adjusted EBITDA 1”
urban-gro, Inc. reported full year ended December 31, 2023 results: revenue $71.5 million, net income $(18.7) million.
“Full Year 2023 Results vs Prior Year Period: • Revenue of $71.5 million , a 6.7% increase from $67.0 million • Net income (loss) of $(18.7) million , as compared to $(15.3) million”
urban-gro, Inc. reported fourth quarter ended December 31, 2023 results: revenue $15.0 million, net income $4.7 million, EPS $(0.40) per share.
“Revenue was $15.0 million , as compared to $17.3 million in the prior year period. This decrease from the prior year period was driven by lower construction Design-Build revenue of $1.3 million , and lower professional services revenue of $0.8 million . Gross profit was $1.7 million , or 11% of revenue as compared to $3.2 million , or 19% of revenue in the prior year period. The decrease in gross profit correlates to the decrease in revenue as well as a shift in mix toward lower margin construction design-build revenue. This was further impacted by a project cost revision in the fourth quarter that negatively impacted project profitability. Operating expenses were $6.4 million as compared to $6.2 million in the prior year period, representing an increase of $0.2 million . The increase in operating expenses was primarily due to increased legal expenses. On an annualized basis, the Company expects a year-over-year reduction of more than $8.0 million in operating expenses in 2024 primaril”
Braze, Inc. reported the quarter and fiscal year ended January 31, 2024 results: revenue $131.0 million, EPS $0.29.
“Revenue was $131.0 million compared to $98.7 million in the fourth quarter of the fiscal year ended January 31, 2023”
Braze, Inc. reported the fiscal year ended January 31, 2024 results: revenue $471.8 million, EPS $(1.32). Guidance initiated.
“Revenue was $471.8 million compared to $355.4 million in the fiscal year ended January 31, 2023”
Super League Enterprise, Inc. reported preliminary financial results for fiscal quarter and year ended December 31, 2023.
“On March 27, 2024, Super League Enterprise, Inc. (the " Company ") released its preliminary financial results for the fiscal quarter and year ended December 31, 2023”
Gamida Cell Ltd. reported financial results for the fourth quarter and full year ended December 31, 2023.
“reported financial results for the fourth quarter and full year ended December 31, 2023”
Aqua Metals, Inc. reported the full-year ended December 31, 2023 results: net income $23.9 million, EPS $(0.25) per basic and diluted share.
“The net loss for 2023 was $23.9 million, or $(0.25) per basic and diluted share, compared to a net loss of $15.4 million, or $(0.20) per basic and diluted share, for 2022.”
Evofem Biosciences, Inc. reported three months ended December 31, 2023 results: revenue $4.8 million.
“For the three months ended December 31, 2023, net product sales were $4.8 million compared to $0.2 million in the prior year period.”
Evofem Biosciences, Inc. reported year ended December 31, 2023 results: revenue $18.2 million.
“For the year ended December 31, 2023, net product sales were $18.2 million compared to $16.8 million in net product sales in the prior year.”
Celcuity Inc. reported the fourth quarter and fiscal year ended December 31, 2023 results: net income Net loss for the fourth quarter of 2023 was $18.8 million, or $0.65 loss per share, compared to a net loss of $11.6 mill, EPS $0.65 loss per share.
“Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ended December 31, 2023”
Matinas BioPharma Holdings, Inc. reported financial results for for the year and quarter ended December 31, 2023.
“On March 27, 2024, Matinas BioPharma Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the year and quarter ended December 31, 2023.”
Odysight.ai Inc. reported the year ended December 31, 2023 results: revenue $3.0 million.
“Commission. As of December 31, 2023, Odysight.ai had $17.0 million of cash and short-term deposits on its balance sheet. Key highlights: ● The Company reported revenues of $3.0 million in the year ended of December 31, 2023, compared to $0.7 million in year ended on December 31, 2022, an increase of more than 350%. ● The Company achieved a positive gross”
Sprinklr, Inc. reported the fiscal year ended January 31, 2024 results: revenue $732.4 million, net income net income per share, basic was $0.19, EPS $0.19.
“Full Year Fiscal 2024 Financial Highlights • Revenue : Total revenue for fiscal year 2024 was $732.4 million”
Sprinklr, Inc. reported the fourth quarter ended January 31, 2024 results: revenue $194.2 million, net income net income per share, basic was $0.08, EPS $0.08.
“Fourth Quarter Fiscal 2024 Financial Highlights • Revenue : Total revenue for the fourth quarter was $194.2 million”
RH reported fourth quarter and fiscal year 2023 ended February 3, 2024 results: revenue GAAP Net Revenues of $3.029B, net income GAAP Net Income of $128M.
“FISCAL 2023 HIGHLIGHTS GAAP Net Revenues of $3.029B, GAAP Operating Margin of 12.1%, Adjusted Operating Margin of 13.0%, GAAP Net Income of $128M, Adjusted Net Income of $147M, Adjusted EBITDA Margin of 18.2%”
Aura Biosciences, Inc. reported financial results for fourth quarter and year ended December 31, 2023.
“On March 27, 2024, Aura Biosciences, Inc., issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2023.”
PDS Biotechnology Corp reported the year ended December 31, 2023 results: net income Net loss for the year ended December 31, 2023, was approximately $42.9 million, or $1.39 per basic and diluted share, EPS $1.39 per basic and diluted share.
“Net loss for the year ended December 31, 2023, was approximately $42.9 million, or $1.39 per basic and diluted share, compared to a net loss of $40.9 million, or $1.43 per basic share and diluted share, for the year ended December 31, 2022.”
PALISADE BIO, INC. reported financial results for the year ended December 31, 2023.
“Palisade Bio, Inc. (the "Company") reported its financial results for the year ended December 31, 2023. A copy of the press release is attached as Exhibit 99.01 and is incorporated herein by reference.”
PRECISION BIOSCIENCES INC reported financial results for quarter and fiscal year ended December 31, 2023.
“On March 27, 2024, Precision BioSciences, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2023.”
Altimmune, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.
“Altimmune, Inc. (the “Company”) issued a press release announcing the Company’s financial results for its full year and fiscal quarter ended December 31, 2023.”
Cellectar Biosciences, Inc. reported financial results for year ended December 31, 2023.
“Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2023, and provided a corporate update.”
CRESCENT BIOPHARMA, INC. reported financial results for the quarter and year ended December 31, 2023.
“On March 27, 2024, GlycoMimetics, Inc. (the “ Company ”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.”
DNA X, Inc. reported the fiscal year ended December 31, 2023 results: revenue $93.6 million, net income $90 thousand.
“Full Year 2023 and Recent Highlights ● Net revenues increased by 34% year-over-year, to $93.6 million, up from $69.8 million in 2022 ● GAAP net loss for the full year improved to $90 thousand, down from a net loss of $14.1 million in 2022”
VERINT SYSTEMS INC reported the year ending January 31, 2025 results: revenue $930 million +/- 2%, EPS $2.89 at the midpoint of our revenue guidance. Guidance raised.
“Revenue : $930 million +/- 2%, reflecting 5% year-over-year growth (growth rate adjusted for divestiture)”
VERINT SYSTEMS INC reported the year ended January 31, 2024 results: revenue $910 million on a GAAP basis and $911 million on a non-GAAP basis, EPS $0.28 on a GAAP basis and $2.73 on a non-GAAP basis. Guidance raised.
“Revenue for the year ended January 31, 2024 was $910 million on a GAAP basis and $911 million on a non-GAAP basis.”
VERINT SYSTEMS INC reported the three months ended January 31, 2024 results: revenue $265 million, EPS $0.37 on a GAAP basis and $1.07 on a non-GAAP basis. Guidance raised.
“Revenue for the three months ended January 31, 2024 was $265 million, representing 12% year-over-year growth.”
CARNIVAL PLC reported first quarter 2024 results: revenue $5.4 billion.
“CARNIVAL CORPORATION & PLC REPORTS RECORD FIRST QUARTER REVENUES AND ALL-TIME RECORD BOOKING LEVELS MIAMI (March 27, 2024) - Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) announced financial results for the first quarter 2024 and provided an outlook for the full year and second quarter 2024. • Record first quarter revenues of $5.4 billion with record net yields (in constant currency) and record net per diems (in constant currency) both significantly exceeding 2023 levels (see”
Koil Energy Solutions, Inc. reported Q4 2023 (three months ended December 31, 2023) and full-year 2023 results: revenue $4.0 million for Q4 2023; $15.3 million for full-year 2023, net income net loss of $0.9 million for Q4 2023; net loss of $1.6 million for full-year 2023, EPS $0.07 loss per diluted share for Q4 2023; $0.13 loss per diluted share for full-year 2023.
“Due to the factors discussed above, Koil Energy reported a Q4 2023 net loss of $0.9 million, or a $0.07 loss per diluted share, compared to a Q4 2022 net loss of $1.3 million, or an $0.11 loss per diluted share. Our full-year 2023 net loss was $1.6 million, or a $0.13 loss per diluted share, compared to our full-year 2022 net loss of $2.9 million, or a $0.24 loss per diluted share.”
GAIA, INC reported the year ended December 31, 2023 results: revenue $80.4 million, net income $(5.6) million, EPS $(0.27) per share. Guidance reaffirmed.
“Revenue for the year was $80.4 million as compared to $82.0 million in 2022”
GAIA, INC reported the quarter ended December 31, 2023 results: revenue $20.7 million, net income $(1.8) million, EPS $(0.08) per share. Guidance reaffirmed.
“Revenues for the fourth quarter 2023 increased 6% to $20.7 million from $19.6 million in the fourth quarter of 2022”
DURECT CORP reported fourth quarter and full year 2023 results: revenue $2.7 million, net income net loss was $1.4 million.
“Total revenues were $2.7 million and net loss was $1.4 million for the three months ended December 31, 2023 compared to total revenues of $3.3 million and net loss of $10.5 million for the three months ended December 31, 2022. Total revenues were $8.5 million and net loss was $27.6 million for the year ended December 31, 2023, compared to total revenues of $19.3 million and net loss of $35.3 million for the year ended December 31, 2022.”
Usio, Inc. reported the fourth quarter and year 2023, which ended December 31, 2023 results: revenue $ 82.6 million. Guidance reaffirmed.
“31, 2023 . Louis Hoch, Chairman and Chief Executive Officer of Usio, said, “For the seventh consecutive year, Usio achieved record revenues, with full year 2023 revenues of $ 82.6 million, up 19% . In addition, Adjusted EBITDA 1 totaled $2.4 million for the year. Both of these results met the fiscal 2023 Guidance established at the outset of 2023, illustrating”
SONIDA SENIOR LIVING, INC. reported fourth quarter and full year ended December 31, 2023 results: net income Net loss for the fourth quarter was $14.6 million..
“Sonida Senior Living, Inc. Announces Fourth Quarter and Full Year 2023 Results”
INTEST CORP reported financial results for the fourth quarter and year ended December 31, 2023.
“On March 27, 2024, inTEST Corporation (the "Company") issued a press release regarding its financial results for the fourth quarter and year ended December 31, 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.